文献速递腹部MR

MRI特征能否预测肝细胞癌临床相关基因亚型?

Can MRI features predict clinically relevant hepatocellular carcinoma genetic subtypes?
PubMed 文献 · Abdom Radiol (NY) · 2023-03-18

本研究对42例患者的43个病理证实肝细胞癌行447个癌症相关基因测序,并回顾性评估MRI特征。TP53突变与浸润性肿瘤边缘相关(p=0.01),CTNNB1突变与瘤周强化相关(p=0.04)。浸润性边缘预测TP53突变的准确度74.4%、敏感度61.5%、特异度80.0%;瘤周强化预测CTNNB1突变的准确度69.8%、敏感度47.0%、特异度84.6%。

要点

  • 浸润性肿瘤边缘与TP53突变相关,特异度80.0%,读者间一致性近乎完美(kappa=0.95)。
  • 瘤周强化与CTNNB1突变相关,特异度84.6%,读者间一致性中等(kappa=0.74)。
  • 缺乏上述MRI特征可能是相应基因亚型的阴性预测指标,与预后和治疗反应相关。

关键影像表现/征象

  • TP53突变肿瘤更常表现为浸润性肿瘤边缘(p=0.01),读者间一致性近乎完美(kappa=0.95)。
  • CTNNB1突变与瘤周强化相关(p=0.04),读者间一致性中等(kappa=0.74)。
  • 评估的MRI特征包括肿瘤大小、浸润性边缘、弥散受限、动脉期高强化、非周边廓清、强化包膜、瘤周强化、静脉癌栓、肿块内脂肪、肿块内血液产物、肝硬化和肿瘤异质性。

诊断标准与关键数值

  • 浸润性肿瘤边缘预测TP53突变:准确度74.4%,敏感度61.5%,特异度80.0%。
  • 瘤周强化预测CTNNB1突变:准确度69.8%,敏感度47.0%,特异度84.6%。
  • TP53突变频率13/43(30%),CTNNB1突变频率17/43(40%)。

临床应用与阅片要点

  • 阅片时注意评估肿瘤边缘是否呈浸润性及是否存在瘤周强化,可提示相应基因亚型。
  • 上述特征特异度较高但敏感度有限,阴性结果不能排除相应突变。
  • 读者间一致性较好,尤其浸润性边缘(kappa=0.95),支持其作为可重复评估的影像标志。

局限性

  • 回顾性研究,样本量较小(43个病灶来自42例患者)。
  • 单中心研究,未报告外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Recent studies in cancer genomics have revealed core drivers for hepatocellular carcinoma (HCC) pathogenesis. We aim to study whether MRI features can serve as non-invasive markers for the prediction of common genetic subtypes of HCC.

METHODS: Sequencing of 447 cancer-implicated genes was performed on 43 pathology proven HCC from 42 patients, who underwent contrast-enhanced MRI followed by biopsy or resection. MRI features were retrospectively evaluated including tumor size, infiltrative tumor margin, diffusion restriction, arterial phase hyperenhancement, non-peripheral washout, enhancing capsule, peritumoral enhancement, tumor in vein, fat in mass, blood products in mass, cirrhosis and tumor heterogeneity. Fisher's exact test was used to correlate genetic subtypes with imaging features. Prediction performance using correlated MRI features for genetic subtype and inter-reader agreement were assessed.

RESULTS: The two most prevalent genetic mutations were TP53 (13/43, 30%) and CTNNB1 (17/43, 40%). Tumors with TP53 mutation more often demonstrated an infiltrative tumor margin on MRI (p = 0.01); inter-reader agreement was almost perfect (kappa = 0.95). The CTNNB1 mutation was associated with peritumoral enhancement on MRI (p = 0.04), inter-reader agreement was substantial (kappa = 0.74). The MRI feature of an infiltrative tumor margin correlated with the TP53 mutation with accuracy, sensitivity, and specificity of 74.4%, 61.5% and 80.0%, respectively. Peritumoral enhancement correlated with the CTNNB1 mutation with accuracy, sensitivity, and specificity of 69.8%, 47.0% and 84.6%, respectively.

CONCLUSION: An infiltrative tumor margin on MRI correlated with TP53 mutation and peritumoral enhancement correlated with CTNNB1 mutation in HCC. Absence of these MRI features are potential negative predictors of the respective HCC genetic subtypes that have implications for prognosis and treatment response.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Liu, Guo, Zhao, et al. Can MRI features predict clinically relevant hepatocellular carcinoma genetic subtypes? Abdom Radiol (NY). 2023. PMID: 36933025. doi:10.1007/s00261-023-03876-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。